Goldline Pharmaceutical Ltd.
Company snapshot
Goldline Pharmaceutical Ltd.
Pharmaceuticals
₹41 cr
P/E 9.84×
Latest quarter · Mar 2026
Sales₹17 cr
Net profit₹3 cr
Op. margin+24.9%
EPS₹4.00
Strength & growth
Debt / equity1.07×
Current ratio1.98×
The timeline — 2 notes on Goldline Pharmaceutical Ltd.
June 2026
- 23 Jun 26 · 8:40 PM IST Lead Lead · Micro cap
Goldline promoter lifts stake to 29.27% with open-market buy
Swapan Khandelwal bought 60,000 shares (0.62% of equity) on 22 June. No pledging. For a nano-cap with a market cap of just ₹42 cr, it's a rare vote of confidence.
- 09 Jun 26 · 6:56 PM IST Brief Brief · Earnings · Micro cap
Goldline Pharmaceutical's profit jumps 45% to ₹411.71 lacs in FY26
The nano-cap drugmaker's first full-year audited results show profit outpacing revenue growth. Revenue rose 11% to ₹3,119.76 lacs.